Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy in adults and accounts for 85–90% of all primary liver cancer. Based on the estimation by the International Agency for Research on Cancer in 2018, liver cancer is the fourth leading cause of cancer death globally. Dihydroarte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Huang, Tzu-En, Deng, Yi-Ning, Hsu, Jui-Ling, Leu, Wohn-Jenn, Marchesi, Elena, Capobianco, Massimo L., Marchetti, Paolo, Navacchia, Maria Luisa, Guh, Jih-Hwa, Perrone, Daniela, Hsu, Lih-Ching
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7748086/
https://ncbi.nlm.nih.gov/pubmed/33343369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.599067
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados